Rituximab, a new treatment for difficult-to-treat chronic erythema multiforme major? Five cases

Background Erythema multiforme major (EMM) is an inflammatory disease affecting skin and mucosae, often triggered by infection with Herpes simplex virus. Some patients have a chronic disease associated with antidesmoplakin autoantibodies, but the pathophysiology remains to be elucidated. First‐line...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2016-07, Vol.30 (7), p.1140-1143
Hauptverfasser:	Hirsch, G., Ingen-Housz-Oro, S., Fite, C., Valeyrie-Allanore, L., Ortonne, N., Buffard, V., Verlinde-Carvalho, M., Marinho, E., Martinet, J., Grootenboer-Mignot, S., Descamps, V., Wolkenstein, P., Joly, P., Chosidow, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Erythema Multiforme - drug therapy Female Humans Male Middle Aged Rituximab - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!